Bacil Pharma informs about closure of trading window

21 Jan 2017 Evaluate

Bacil Pharma has informed that the Meeting of Board of Directors of the Company will be held on January 30, 2017, to consider and approve the Unaudited Financial Results of the Company for the Quarter and Nine Month ended December 31, 2016. Further, pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, the trading window for dealing in securities of the Company would remain closed for all the employees/Directors/designated persons of the Company from January 21, 2017 to February 01, 2017.

The above information is a part of company’s filings submitted to BSE.

Bacil Pharma Share Price

5.35 0.25 (4.90%)
May 27, 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 903.95
Cipla 966.30
Dr. Reddy's Lab 4392.00
Aurobindo Pharma 529.60
Lupin 606.15
View more..